Short-term ANG II produces renal vasoconstriction independent of TP receptor activation and TxA2/isoprostane production

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 3, 2007, Pages

  Vågnes, Øyvind B ^a,c   Iversen, Bjarne M ^c   Arendshorst, William J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Glomerular arterioles; Isoprostane; Kidney; Oxidative stress; Prostanoids; Renal circulation; Renin angiotensin system

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; ANGIOTENSIN II; ISOPROSTANE; PROSTANOID RECEPTOR; THROMBOXANE A2; THROMBOXANE RECEPTOR;

ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; GLOMERULUS; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY CIRCULATION; KIDNEY VASCULAR RESISTANCE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; URINARY EXCRETION; VASOCONSTRICTION;

EID: 34548652696     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00510.2006     Document Type: Article

References (59)

1. Abe T, Takeuchi K, Takahashi N, Tsutsumi E, Taniyama Y, Abe K. Rat kidney thromboxane receptor: molecular cloning, signal transduction, and intrarenal expression localization. J Clin Invest 96: 657-664, 1995.
2. Aiken JW, Vane JR. Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 184: 678-687, 1973.
3. Badahman AH, Wilson TW. A renal vasodilator effect of angiotensin II revealed by dual thromboxane inhibition. Canadian J Physiol Pharmacol 72: 632-636, 1994.
4. Boffa JJ, Arendshorst WJ. Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock. J Am Soc Nephrol 16: 124, 2005.
5. Boffa JJ, Just A, Coffman TM, Arendshorst WJ. Thromboxane receptor mediates renal vasoconstriction and contributes to acute renal failure in endotoxemic mice. J Am Soc Nephrol 15: 2358-2365, 2004.
6. 2 and renovascular hypertension in rats. Am J Physiol Regul Integr Comp Physiol 267: R1190-R1197, 1994.
7. 2 contributes to the enhanced tubuloglomerular feedback activity in young SHR. Am J Physiol Renal Physiol 276: F758-F766, 1999.
8. Brannstrom K, Morsing P, Arendshorst WJ. Exaggerated tubuloglomerular feedback activity in genetic hypertension is mediated by ANG II and AT1 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 270: F749-F755, 1996.
9. Cediel E, De Las HN, Sanz-Rosa D, Velasco O, Cachofeiro V, Lahera V. AT-1 receptor antagonism modifies the mediation of endothelin-1, thromboxane A2, and catecholamines in the renal constrictor response to angiotensin II. Kidney Int Suppl 93: S3-S9, 2005.
10. Cediel E, Vazquez-Cruz B, Navarro-Cid J, De Las HN, Sanz-Rosa D, Cachofeiro V, Lahera V. Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension. Kidney Int Suppl 82: S2-S7, 2002.
11. Chatziantoniou C, Arendshorst WJ. Angiotensin and thromboxane in genetically hypertensive rats: renal blood flow and receptor studies. Am J Physiol Renal Fluid Electrolyte Physiol 261: F238-F247, 1991.
12. Chatziantoniou C, Arendshorst WJ. Impaired ability of prostaglandins to buffer renal vasoconstriction in genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 263: F573-F580, 1992.
13. Chatziantoniou C, Daniels FH, Arendshorst WJ. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 259: F372-F382, 1990.
14. Chatziantoniou C, Ruan X, Arendshorst WJ. Interactions of cAMP-mediated vasodilators with angiotensin II in rat kidney during hypertension. Am J Physiol Renal Fluid Electrolyte Physiol 265: F845-F852, 1993.
15. Cruz BV, Escalante B. Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension. J Cardiovasc Pharmacol 34: 21-27, 1999.
16. Dunn MJ, Hood VL. Prostaglandins and the kidney. Am J Physiol Renal Fluid Electrolyte Physiol 233: F169-F184, 1977.
17. Ercan ZS, Sindel S, Turker R. Possible thromboxane A2 mediated effect of angiotensin II in the rabbit isolated perfused kidney. Arch Int Physiol Biochim Biophys 99: 397-400, 1991.
18. Feng JJ, Arendshorst WJ. Enhanced renal vasoconstriction induced by vasopressin in SHR is mediated by V1 receptors. Am J Physiol Renal Fluid Electrolyte Physiol 271: F304-F313, 1996.
19. Finn WF, Arendshorst WJ. Effect of prostaglandin synthetase inhibitors on renal blood flow in the rat. Am J Physiol 231: 1541-1545, 1976.
20. Francois H, Athirakul K, Mao L, Rockman H, Coffman TM. Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43: 364-369, 2004.
21. Goto F, Jackson EK, Ohnishi A, Herzer W, Branch RA. Effect of cyclooxygenase and thromboxane synthase inhibition on the response to angiotensin II in the hypoperfused canine kidney. J Pharmacol Exp Ther 243: 799-803, 1987.
22. Grone HJ, Grippo RS, Arendshorst WJ, Dunn MJ. Role of thromboxane in control of arterial pressure and renal function in young spontaneously hypertensive rats. Am J Physiol Renal Fluid Electrolyte Physiol 250: F488-F496, 1986.
23. Himmelstein SI, Klotman PE. The role of thromboxane in two-kidney, one-clip Goldblatt hypertension in rats. Am J Physiol Renal Fluid Electrolyte Physiol 257: F190-F196, 1989.
24. Jackson EK, Herzer WA. Defective modulation of angiotensin IIinduced renal vasoconstriction in hypertensive rats. Hypertension 23: 329-336, 1994.
25. Just A, Olson AJ, Falck JR, Arendshorst WJ. NO and NO-independent mechanisms mediate ETB receptor buffering of ET-1-induced renal vasoconstriction in the rat. Am J Physiol Regul Integr Comp Physiol 288: R1168-R1177, 2005.
26. Just A, Olson AJ, Whitten CL, Arendshorst WJ. Superoxide mediates acute renal vasoconstriction produced by angiotensin II and catecholamines by a mechanism independent of nitric oxide. Am J Physiol Heart Circ Physiol 292: H83-H92, 2007.
27. Kaushal RD, Wilson TW. Effect of furegrelate on renal plasma flow after angiotensin II infusion. Can J Physiol Pharmacol 68: 500-504, 1990.
28. Kawada N, Dennehy K, Solis G, Modlinger P, Hamel R, Kawada JT, Aslam S, Moriyama T, Imai E, Welch WJ, Wilcox CS. TP receptors regulate renal hemodynamics during angiotensin II slow pressor response. Am J Physiol Renal Physiol 287: F753-F759, 2004.
29. Lebel M, Grose JH, Falardeau P. Modulation of renal hemodynamics by renal eicosanoids during vasopressor infusions in man. Prostaglandins Leukot Essent Fatty Acids 35: 41-49, 1989.
30. Liu KL, Aissa AH, Lareal MC, Benzoni D, Vincent M, Sassard J. Adrenergic stimulation of renal prostanoids in the Lyon hypertensive rat. Hypertension 17: 296-302, 1991.
31. Liu KL, Benzoni D, Sassard J. Prostaglandin H2-thromboxane A2 and renal functions in the Lyon hypertensive rat. Am J Physiol Regul Integr Comp Physiol 266: R1530-R1536, 1994.
32. Matsuda H, Hayashi K, Arakawa K, Kubota E, Honda M, Tokuyama H, Suzuki H, Yamamoto T, Kajiya F, Saruta T. Distinct modulation of superficial and juxtamedullary arterioles by prostaglandin in vivo. Hypertens Res 25: 901-910, 2002.
33. Mistry M, Muirhead EE, Yamaguchi Y, Nasjletti A. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade. J Hypertens 8: 75-83, 1990.
34. Mistry M, Nasjletti A. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension. Hypertension 11: 758-762, 1988.
35. Mistry M, Nasjletti A. Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension. Adv Prostaglandin Thromboxane Leukot Res 19: 207-210, 1989.
36. Munger KA, Takahashi K, Awazu M, Frazer M, Falk SA, Conger JD, Badr KF. Maintenance of endothelin-induced renal arteriolar constriction in rats is cyclooxygenase dependent. Am J Physiol Renal Fluid Electrolyte Physiol 264: F637-F644, 1993.
37. Olsen ME, Hall JE, Montani JP, Cornell JE. Protection of preglomerular vessels from angiotensin II vasoconstriction by renal prostaglandins. J Hypertens Suppl 3: S255-S258, 1985.
38. Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 48: 323-328, 2006.
39. Quilley J, McGiff JC, Nasjletti A. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat. Br J Pharmacol 96: 111-116, 1989.
40. Ruan X, Chatziantoniou C, Arendshorst WJ. Impaired prostaglandin E2/prostaglandin I2 receptor-Gs protein interactions in isolated renal resistance arterioles of spontaneously hypertensive rats. Hypertension 34: 1134-1140, 1999.
41. Satoh H, Satoh S. Prostaglandin E2 and I2 production in isolated dog renal arteries in the absence or presence of vascular endothelial cells. Biochem Biophys Res Comm 118: 873-876, 1984.
42. Scharschmidt LA, Lianos E, Dunn MJ. Arachidonate metabolites and the control of glomerular function. Federation Proc 42: 3058-3063, 1983.
43. Sigmon DH, Beierwaltes WH. Endothelium-derived constricting factor in renovascular hypertension. Hypertension 25: 803-808, 1995.
44. Silldorff EP, Hilbun LR, Pallone TL. Angiotensin II constriction of rat vasa recta is partially thromboxane dependent. Hypertension 40: 541-546, 2002.
45. Steinhelper ME, Cochrane K, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension (Dallas) 16: 301-307, 1990.
46. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, Hoover RL, Badr KF. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. J Clin Invest 90: 136-141, 1992.
47. Takahashi N, Takeuchi K, Abe T, Sugawara A, Abe K. Immunolocalization of rat thromboxane receptor in the kidney. Endocrinology 137: 5170-5173, 1996.
48. 1 receptors in renal resistance vessels of rats developing genetic hypertension. Am J Physiol Renal Physiol 278: F940-F948, 2000.
49. 2+ response to AVP in preglomerular vessels from rats with genetic hypertension during different hydration states. Am J Physiol Renal Physiol 288: F1249-F1256, 2005.
50. Vallotton MB, Wuthrich RP. The regulation of prostaglandins by vasoactive hormones in renal tubular and vascular smooth muscle cells. AgentsActions Suppl 22: 27-35, 1987.
51. Vitzthum H, Abt I, Einhellig S, Kurtz A. Gene expression of prostanoid forming enzymes along the rat nephron. Kidney Int 62: 1570-1581, 2002.
52. Wang D, Chabrashvili T, Wilcox CS. Enhanced contractility of renal afferent arterioles from angiotensin-infused rabbits: roles of oxidative stress, thromboxane prostanoid receptors, and endothelium. Circ Res 94: 1436-1442, 2004.
53. 2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat. Am J Physiol Regul Integr Comp Physiol 271: R891-R896, 1996.
54. Wilcox CS, Welch WJ. Angiotensin II and thromboxane in the regulation of blood pressure and renal function. Kidney Int Suppl 30: S81-S83, 1990.
55. Wilcox CS, Welch WJ. Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens 3: 242-249, 1990.
56. Wilcox CS, Welch WJ, Snellen H. Thromboxane mediates renal hemodynamic response to infused angiotensin II. Kidney Int 40: 1090 -1097, 1991.
57. Williams JM, Pollock DM. Contribution of prostanoid TP receptors to the pressor and intrarenal haemodynamic response to endothelin. Clin Exp Pharmacol Physiol 33: 253-257, 2006.
58. Yamaguchi Y, Fenoy FJ, Roman RJ, Nasjletti A. Angiotensin II influences the renal hemodynamic response to blockade of thromboxane A2 and prostaglandin H2 receptors. J Pharmacol Exp Ther 263: 905-909, 1992.
59. Yanagisawa H, Wada O. Effects of dietary protein on eicosanoid production in rat renal tubules. Nephron 78: 179-186, 1998.